Our study provides insight into the tumor suppressor function of ING4 in breast cancer and offers a molecular basis to explore the ING4/NF-κB pathway as a potential therapeutic target in order to block disease progression and improve patient survival. This evidence concerns the gene NFKB1 and breast carcinoma.